We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




DNA Biosensor Enables Early Diagnosis of Cervical Cancer

By LabMedica International staff writers
Posted on 21 Dec 2023
Print article
Image: The electrochemical sensor detects HPV-16 and HPV-18 with high specificity (Photo courtesy of 123RF)
Image: The electrochemical sensor detects HPV-16 and HPV-18 with high specificity (Photo courtesy of 123RF)

Molybdenum disulfide (MoS2), recognized for its potential to form two-dimensional nanosheets like graphene, is a material that's increasingly catching the eye of the scientific community. These nanosheets are formed through the stacking of S–Mo–S layers that are held together by Van der Waals forces. MoS2's distinctive structural, optical, thermal, and electrochemical attributes have paved the way for research in diverse domains, including biomolecule sensing, optoelectronics, energy storage, and more. Historically, carbon nanostructures have been used as an immobilization platform for DNA. To replace carbon with MoS2 as an effective electrochemical DNA sensor, the electrical conductivity of MoS2 must be improved significantly.

To tackle this challenge, researchers at Chung-Ang University (Seoul, South Korea) have devised an electrochemical DNA biosensor using a composite of graphitic nano-onions and MoS2 nanosheets. This biosensor shows promise in detecting human papillomavirus (HPV) types 16 and 18, offering the potential for early cervical cancer diagnosis. The team measured the biosensor's sensitivity to these HPV types using the differential pulse voltammetry (DPV) technique in conjunction with methylene blue (MB) as a redox indicator. They observed that the nano-onion/MoS2 nanosheet composite electrode demonstrated higher current peaks than its MoS2-only counterpart, suggesting enhanced conductive electron transfer facilitated by the nano-onions.

This enhancement led to the effective and specific detection of target DNAs from HPV-16 and HPV-18 Siha and Hela cancer cell lines. As a result, MoS2 nanosheets with improved electrical conductivity, when combined with nano-onions, have shown potential as a robust platform for creating electrochemical biosensors that can efficiently diagnose various health conditions, including cervical cancer. Moreover, the integration of nano-onions or nanodiamonds with various organic biomaterials could lead to advancements in chemical functionality, electron transfer conductivity, light absorption, and more. These developments hold promise for groundbreaking applications in disease sensing, targeted drug delivery, and biomedical imaging and diagnostics.

Related Links:
Chung-Ang University 

Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
New
Syphilis Infection Test
IMPACT RPR
New
Gold Member
Strep Pneumoniae Rapid Test
Strep Pneumoniae (6503 – 6573)

Print article

Channels

Microbiology

view channel
Image: The breakthrough system offers a faster way to diagnose bloodborne infections (Photo courtesy of Melio)

Culture-Free Platform Rapidly Identifies Blood Stream Infections

Neonatal sepsis is a life-threatening condition that results from bloodstream infections in newborns under 28 days old. Due to their immature immune systems, newborns are especially vulnerable to infections.... Read more

Pathology

view channel
Image: The technique predicts how well some breast cancer patients will respond to chemotherapy (Photo courtesy of Shutterstock)

New Technique Predicts Tumor’s Responsiveness to Breast Cancer Treatment

Breast cancer is the most common cancer among women worldwide, with 2.3 million new cases diagnosed each year. In the era of personalized medicine, targeted therapies for different types of breast cancer... Read more

Industry

view channel
Image: The game-changing immunoassay diagnostics platform delivers results from whole blood sample in 10 minutes (Photo courtesy of SpinChip)

bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics

bioMérieux (Marcy l’Étoile, France) has agreed to acquire SpinChip Diagnostics (Oslo, Norway), the developer of a game-changing immunoassay diagnostics platform. The small benchtop analyzer is well adapted... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.